Nxera Pharma Co Ltd (SOLTF)
9.72
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Nxera Pharma Revenue (TTM): 88.33M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.33M |
| September 30, 2023 | 88.09M |
| June 30, 2023 | 109.81M |
| March 31, 2023 | 111.37M |
| December 31, 2022 | 113.86M |
| September 30, 2022 | 188.95M |
| June 30, 2022 | 148.43M |
| March 31, 2022 | 155.61M |
| December 31, 2021 | 157.37M |
| September 30, 2021 | 75.26M |
| June 30, 2021 | 89.18M |
| March 31, 2021 | 84.26M |
| December 31, 2020 | 83.53M |
| September 30, 2020 | 59.40M |
| June 30, 2020 | 66.54M |
| March 31, 2020 | 71.42M |
| December 31, 2019 | 89.23M |
| September 30, 2019 | 80.72M |
| June 30, 2019 | 64.11M |
| March 31, 2019 | 54.31M |
| December 31, 2018 | 32.09M |
| September 30, 2018 | 31.13M |
| June 30, 2018 | 45.24M |
| March 31, 2018 | 62.64M |
| December 31, 2017 | 72.07M |
| Date | Value |
|---|---|
| September 30, 2017 | 75.26M |
| June 30, 2017 | 59.84M |
| March 31, 2017 | 174.43M |
| December 31, 2016 | 162.31M |
| September 30, 2016 | 193.40M |
| June 30, 2016 | 202.09M |
| March 31, 2016 | 67.19M |
| December 31, 2015 | 86.46M |
| September 30, 2015 | 47.02M |
| June 30, 2015 | 34.10M |
| March 31, 2015 | 31.67M |
| December 31, 2014 | 11.09M |
| September 30, 2014 | 10.20M |
| June 30, 2014 | 22.41M |
| March 31, 2014 | 20.81M |
| December 31, 2013 | 19.61M |
| September 30, 2013 | 25.06M |
| June 30, 2013 | 22.59M |
| March 31, 2013 | 24.42M |
| December 31, 2012 | 23.72M |
| September 30, 2012 | 16.18M |
| June 30, 2012 | 10.56M |
| March 31, 2012 | 10.95M |
| December 31, 2011 | 10.57M |
| September 30, 2011 | 10.29M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
59.40M
Minimum
Sep 2020
188.95M
Maximum
Sep 2022
101.34M
Average
88.33M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Takeda Pharmaceutical Co Ltd | 29.70B |
| PeptiDream Inc | 202.69M |
| Stemcell Holdings Inc | 9.984M |
| Healios KK | 0.8776M |
| AnGes Inc | 1.075M |